Agios Reports First Quarter 2020 Financial Results and Provides Update on Business Operations and COVID-19 Response

Go back to Agios Reports First Quarter 2020 Financial Results and Provides Update on Business Operations and COVID-19 Response

Agios Pharma (AGIO) Posts Smaller Q1 Loss on Higher Revenues

April 30, 2020 7:09 AM EDT

Agios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($0.59), $1.08 better than the analyst estimate of ($1.67). Revenue for the quarter came in at $87.1 million versus the consensus estimate of $30.83 million.

Though there is no modern playbook for a crisis like the COVID-19 pandemic, we moved quickly to reduce the risk of our teams... More